# Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

> **NCT03774394** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 61 (actual)

## Conditions studied

- Chronic Kidney Disease (CKD)
- Type 2 Diabetes Mellitus (T2DM)
- Coronary Artery Disease (CAD)

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel active metabolite

## Key facts

- **NCT ID:** NCT03774394
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-22
- **Primary completion:** 2022-05-23
- **Final completion:** 2022-05-31
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2023-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774394, "Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03774394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*